logo
AI Icon𝛼SK or Search
ENTITY

NeuroSpectrum Insights (NSIH US)

2
Analysis
Health Care • United States
NeuroSpectrum Insights, Inc. is a medical device company focused on commercializing breakthrough computerized analysis technology for diagnosing neurological and neurodevelopmental disorders. Its first product, GyriCalc™, is a proprietary, patented software solution designed to assist in autism diagnosis by analyzing MRI images. The company is currently pre-revenue and aims to launch GyriCalc in the U.S. and Canadian markets.
more
bearish•NeuroSpectrum Insights
•16 Jul 2026 11:00

NEUROSPECTRUM INSIGHTS (NSIH US): Synthetic Expert Call Transcript (16 Jul 2026)

GyriCalc's regulatory positioning restricts its commercial adoption: The FDA 510(k) clearance (K250686) categorizes it under 21 CFR 892.2050 as a...

Logo
Share
bullish•NeuroSpectrum Insights
•16 Jul 2026 10:28

IPO Databook: NeuroSpectrum Insights (NSIH US) - Jul 2026

NeuroSpectrum Insights is a pre-revenue medical device company commercializing GyriCalc, a patented software for autism diagnosis using MRI...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5

x